These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12467941

  • 1. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression.
    Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S, Shanks N.
    Psychiatry Res; 2002 Dec 15; 113(1-2):1-15. PubMed ID: 12467941
    [Abstract] [Full Text] [Related]

  • 2. Altered glucocorticoid immunoregulation in treatment resistant depression.
    Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S, Shanks N.
    Psychoneuroendocrinology; 2003 Jan 15; 28(1):49-65. PubMed ID: 12445836
    [Abstract] [Full Text] [Related]

  • 3. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M.
    Depress Anxiety; 2003 Jan 15; 17(1):43-8. PubMed ID: 12577277
    [Abstract] [Full Text] [Related]

  • 4. In search of the HPA axis activity in unipolar depression patients with childhood trauma: Combined cortisol awakening response and dexamethasone suppression test.
    Lu S, Gao W, Huang M, Li L, Xu Y.
    J Psychiatr Res; 2016 Jul 15; 78():24-30. PubMed ID: 27049575
    [Abstract] [Full Text] [Related]

  • 5. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 15; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 6. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression.
    Maes M, Meltzer HY, D'Hondt P, Cosyns P, Blockx P.
    Psychoneuroendocrinology; 1995 Jul 15; 20(2):149-67. PubMed ID: 7899535
    [Abstract] [Full Text] [Related]

  • 7. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 8. Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression.
    Maes M, Meltzer HY, Stevens W, Cosyns P, Blockx P.
    Psychol Med; 1994 Feb 15; 24(1):167-77. PubMed ID: 8208882
    [Abstract] [Full Text] [Related]

  • 9. Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa.
    Gordon CM, Emans SJ, DuRant RH, Mantzoros C, Grace E, Harper GP, Majzoub JA.
    Eat Weight Disord; 2000 Sep 15; 5(3):175-82. PubMed ID: 11082797
    [Abstract] [Full Text] [Related]

  • 10. Are the thyroid and adrenal system alterations linked in depression?
    Mokrani MC, Duval F, Erb A, Gonzalez Lopera F, Danila V.
    Psychoneuroendocrinology; 2020 Dec 15; 122():104831. PubMed ID: 33068950
    [Abstract] [Full Text] [Related]

  • 11. Neonatal glucocorticoid treatment: long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents.
    Ter Wolbeek M, Kavelaars A, de Vries WB, Tersteeg-Kamperman M, Veen S, Kornelisse RF, van Weissenbruch M, Baerts W, Liem KD, van Bel F, Heijnen CJ.
    Brain Behav Immun; 2015 Mar 15; 45():128-38. PubMed ID: 25449580
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression.
    Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH.
    Psychol Med; 2002 Aug 15; 32(6):1021-8. PubMed ID: 12214783
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extent of cortisol suppression at baseline predicts improvement in HPA axis function during antidepressant treatment.
    Scherf-Clavel M, Wurst C, Nitschke F, Stonawski S, Burschka C, Friess L, Unterecker S, Hommers L, Deckert J, Domschke K, Menke A.
    Psychoneuroendocrinology; 2020 Apr 15; 114():104590. PubMed ID: 32006918
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.
    Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW.
    J Clin Endocrinol Metab; 1998 Jan 15; 83(1):47-54. PubMed ID: 9435415
    [Abstract] [Full Text] [Related]

  • 17. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL.
    J Psychiatr Res; 2017 Feb 15; 85():66-74. PubMed ID: 27837659
    [Abstract] [Full Text] [Related]

  • 18. Different responses to dexamethasone and prednisolone in the same depressed patients.
    Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM.
    Psychopharmacology (Berl); 2006 Dec 15; 189(2):225-35. PubMed ID: 17016711
    [Abstract] [Full Text] [Related]

  • 19. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul 15; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 20. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 15; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.